Patients with Diabetes Face Higher Risk for Left-sided Valvular Stenotic Lesions
June 14, 2022

A new study found patients with T1D and T2D had a greater risk for stenotic lesions, whereas risk for valvular regurgitation was lower in those with T2D.

Study: AI-powered Intervention Led to Highest Reported Rate of T2D Remission to Date
June 07, 2022

ADA 2022: Patients with T2D who received a treatment intervention powered by artificial intelligence achieved a remission rate of more than 80%.

Dulaglutide Improves HbA1c for Youth with Type 2 Diabetes without Change in BMI
June 07, 2022

ADA 2022: "Breakthrough" findings may help to address the unmet need for additional treatment options for young patients with type 2 diabetes.

Younger Age and Higher HbA1c Among Factors Linked to CGM Uptake in New Study
June 06, 2022

ADA 2022: Younger age, insulin use, higher HbA1c, and higher diabetes distress were found to be associated with CGM uptake in prospective study.

Patients with Diabetes Up to 4-times More Likely to Develop Long COVID-19
June 04, 2022

ADA 2022: In a new literature review, 43% of studies included identified diabetes as a potent risk for developing post-acute sequelae of COVID-19.

Tirzepatide Treatment Leads to Weight Loss of up to 22.5% in SURMOUNT-1 Clinical Trial
June 04, 2022

ADA 2022: Tirzepatide led overall to weight loss of up to 22.5% of baseline body weight with persons taking the 15 mg dose losing an average of 52 pounds.

Diabetes Device Comparison Made Easy: The Story Behind DiabetesWise Pro
May 23, 2022

Compare, contrast, price shop, prescribe. DiabetesWise Pro developer Korey Hood, PhD, highlights the tool all primary care clinicians should try.

SGLT-2 Inhibitors Belong to Patients, Not a Specialty or Primary Care: Experts Discuss
May 18, 2022

Mikhail Kosiborod, MD, a cardiologist and Neil Skolnik, MD, a primary care physician, agree that whoever is seeing the patient should prescribe the drug that is needed.

Tailored Diabetes Risk Assessment May Reduce Racial/Ethnic Disparities in Diagnosis
May 11, 2022

Lowering thresholds for BMI value and age of first diabetes screening among large US minority populations could greatly increase rates of diagnosis and improve care.

Interview: Delay in Second-line T2D Treatment Among Younger US Veterans Sparks Investigator Concern
May 10, 2022

HbA1c levels over time were found higher at initiation of second-line treatment in veterans aged 55 years and younger, a trend unsettling to a new study's lead author.